Kimberly Gentile, VP of Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 5,000 shares at $29.13 ($146K) on 2017-11-01, disclosed to the SEC on 2017-11-02.
Open-market sale of $146k BHVN by VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.13 | 3,586 | $104K | 71.4% |
| 2 | $29.65 | 1,414 | $42K | 28.6% |
| Total | $29.28 avg | 5,000 | $146K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |